| [1] | Heukelbach, J., and Feldmeier, H., “Epidemiological and clinical characteristics of hookworm-related cutaneous larva migrans,” The Lancet Infectious Diseases, 8(5), 302–309, 2008. |
| |
| [2] | Caumes, E., Carrière, J., Guermonprez, G., et al., “Dermatoses associated with travel to tropical countries: a prospective study of the diagnosis and management of 269 patients presenting to a tropical disease unit,” Clinical Infectious Diseases, 20(3), 542–548, 1995. |
| |
| [3] | Jelinek, T., Maiwald, H., Nothdurft, H. D., et al., “Cutaneous larva migrans in travelers: synopsis of histories, symptoms, and treatment of 98 patients,” Clinical Infectious Diseases, 19(6), 1062–1066, 1994. |
| |
| [4] | Schaub, N. A., Perruchoud, A. P., and Buechner, S. A., “Cutaneous larva migrans associated with Löffler’s syndrome,” Dermatology, 205(2), 207–209, 2002. |
| |
| [5] | Neupane, S. K., Shah, S., Neupane, P. K., and Jaishi, P. P., “Cutaneous larva migrans: A case report successfully treated with albendazole,” Annals of Medicine and Surgery, Article 104904, 2022. |
| |
| [6] | Hochedez, P., and Caumes, E., “Hookworm-related cutaneous larva migrans,” Journal of Travel Medicine, 14(5), 326–333, 2007. |
| |
| [7] | Rizzitelli, G., Scarabelli, G., and Veraldi, S., “Albendazole: a new therapeutic regimen in cutaneous larva migrans,” International Journal of Dermatology, 36(9), 700–703, 1997. |
| |